Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Days Sales Outstanding : 18.55 (As of Dec. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Days Sales Outstanding?

Parnell Pharmaceuticals Holdings's average Accounts Receivable for the six months ended in Dec. 2018 was $0.97 Mil. Parnell Pharmaceuticals Holdings's Revenue for the six months ended in Dec. 2018 was $19.03 Mil. Hence, Parnell Pharmaceuticals Holdings's Days Sales Outstanding for the six months ended in Dec. 2018 was 9.27.

The historical rank and industry rank for Parnell Pharmaceuticals Holdings's Days Sales Outstanding or its related term are showing as below:

PARNF's Days Sales Outstanding is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 71.41
* Ranked among companies with meaningful Days Sales Outstanding only.

Parnell Pharmaceuticals Holdings's Days Sales Outstanding declined from Dec. 2016 (48.04) to Dec. 2018 (18.55).

Parnell Pharmaceuticals Holdings Days Sales Outstanding Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Days Sales Outstanding Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

Days Sales Outstanding

Get a 7-Day Free Trial

84.70

60.60

48.04

24.10

18.55

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
Days Sales Outstanding	Get a 7-Day Free Trial			91.69	60.60	48.04	24.10	18.55

Competitive Comparison of Parnell Pharmaceuticals Holdings's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Parnell Pharmaceuticals Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parnell Pharmaceuticals Holdings's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnell Pharmaceuticals Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Parnell Pharmaceuticals Holdings's Days Sales Outstanding falls into.

Parnell Pharmaceuticals Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Parnell Pharmaceuticals Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2018 is calculated as

	Days Sales Outstanding (A: Dec. 2018 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2017 )	+	Accounts Receivable (A: Dec. 2018 ))	/	count )	/	Revenue (A: Dec. 2018 )	*	Days in Period
=	( (0.731	+	1.203)	/	2 )	/	19.031	*	365
=	0.967					/	19.031	*	365
=	18.55

Parnell Pharmaceuticals Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2018 is calculated as:

	Days Sales Outstanding (Q: Dec. 2018 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2017 )	+	Accounts Receivable (A: Dec. 2018 ))	/	count )	/	Revenue (A: Dec. 2018 )	*	Days in Period
=	( (0.731	+	1.203)	/	2 )	/	19.031	*	365 / 2
=	0.967					/	19.031	*	365 / 2
=	9.27

Parnell Pharmaceuticals Holdings (OTCPK:PARNF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Parnell Pharmaceuticals Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.